Pharma's Almanac TV
PA TV
Follow the Completed Journey
Companies We've Met
AES Clean Technology
Altis Biosystems
Arranta Bio
Avara Pharmaceutical Services
Avid Bioservices
BioVectra
Centaur BPS
Dynamk Capital
ECRI
Evolve Biologics
Federal Equipment Company
Globyz
Inceptor Bio
IPS-Integrated Project Services
Olon
Pii
Polpharma Biologics
PPD
RoosterBio
SanaClis
Sanofi AIS
SGD Pharma
SPI Pharma
TriRx Pharmaceutical Services
Yourway
Follow the Completed Journey
Companies On The Road
Follow The Artist
ABS
aCGT Vector
Alconox Inc.
Andelyn Biosciences
Arranta Bio
Avid Bioservices
BDD
BIOVECTRA
DPS Group
Dynamk Capital
Environmental Systems Corporation
Federal Equipment Company
Genesis AEC
Globyz Biopharma Services
Grifols Partnership
IDT Biologika
Inceptor Bio
IPS-Integrated Project Services
Kineticos Life Sciences
MilliporeSigma
Montana BioScience Alliance
Olon
Rentschler Biopharma
SanaClis
Scorpion Biological Services
Secant Group
Tapemark
VITRONIC
Dashboard
Your Name
Your Email
Manage Account
Sign Out
Sign In
Register
Topics
Products
ADC
API - Small Molecule
Biologics
Biopharmaceuticals
Biosimilars
Cell and Gene Therapy
DNA
Drug Product
Drug Substance
Equipment
Generics
Immunotherapy
Injectables
Monoclonal Antibody
Novel Therapeutics
Oral Solid Dosage
Orphan Drugs
Parenterals
Stem Cells
Vaccine
Services
Big Data
Bioprocessing
Clinical Trials
Continuous Manufacturing
Diagnostics
Drug Delivery
Drug Development
Drug Discovery
Facility
Formulation
Innovation
Oncology
Patient Adherence
Patient Centric
Preclinical
Process Development
Quality
Regulatory
Research
Serialization
Segment
Biomanufacturing
Biotechnology
CDMO
Consulting
CRO
Engineering
Equipment
Excipients
Healthcare
Intermediates
Logistics
Manufacturing
Packaging
Supply Chain
Business
Agreement
Appointment
Business
Capacity Expansion
Collaboration
Growth
Investment
Licensing
M&A
Market Expansion
Market Intelligence
Market Prediction
New Facility
Strategic Partnership
Magazine
Archive
Reports
2021 Cell & Gene Therapy Report
2021 Monoclonal Antibody & Recombinant Protein Market Report
2022 Sterile Drug Market Report
2022 API Market Report
2020 OSD Market Report
Community
Company A to Z
Follow the Journey
Companies On The Road
Follow The Artist
More+
Staffing
Media Kit
Drug Discovery (3)
143 Articles Available
3
6
Can't find what you're looking for? Try our
advanced search
.
Drug Development
New Antibiotic to be Tested against Potential Bioweapons
PAO-M07-18-NI-009
Drug Discovery
Peptron Announces Published Data Showing a New Sustained-Release Exendin-4 Formulation Prevents Neurodegeneration in a Parkinson's Disease Model
PR-M07-18-NI-052
Drug Discovery
Could a Bispecific Antibody Be A Functional Cure for AIDS?
PAO-M06-18-NI-015
Drug Approval
WuXi STA First CDMO to Support the Approval of an Innovative Drug in China Through the "MAH" Pilot
PR-M06-18-NI-057
FDA
FDA Advisory Committee Votes in Favor of Cardinal Health's INCRAFT® AAA Stent Graft System for the Endovascular Treatment of Infrarenal Abdominal Aortic Aneurysms
PR-M06-18-NI-055
Drug Discovery
Eisai Inc. to Launch Center for Genetics Guided Dementia Discovery in Cambridge, Massachusetts
PR-M06-18-NI-044
Artificial Intelligence
WuXi AppTec Leads Strategic Investment in Insilico Medicine to Accelerate Drug Discovery Using Next-Generation Artificial Intelligence
PR-M06-18-NI-037
Clinical Data
New Data Demonstrate Artemis Therapeutics' Artemisone May Be An Effective Inhibitor Of Human CMV Replication
PR-M06-18-NI-030
R&D
Researchers Find Link between Tuberculosis and Parkinson’s Disease
PAO-M05-18-NI-025
Inhalation
GSK Applies in Japan for Approval of a Once-Daily, Single Inhaler Triple Therapy for COPD
PAO-M05-18-NI-022
Next-Generation Manufacturing
Thinking a Generation Ahead: Biologics-Based Therapy
PAP-Q2-18-FA-002
Fast Track
Valneva Receives Fast Track Designation for Lyme Disease Vaccine
PAO-M05-18-NI-021
Drug Discovery
RNA-Modifying Proteins May Provide New Drug Targets
PAO-M05-18-NI-018
Treatment
New Single-Pill HIV Treatment Approved in Europe
PAO-M05-18-NI-015
Drug Development
Novartis announces FDA approval of Gilenya® as the first disease-modifying therapy for pediatric relapsing multiple sclerosis
PR-M05-18-NI-060
Drug Discovery
XtalPi Inc. Announces Strategic Research Collaboration with Pfizer Inc. to Develop Artificial Intelligence-Powered Molecular Modeling Technology for Drug Discovery
PR-M05-18-NI-041
Inflammatory Disease
Gilead Sciences and Verily Life Sciences LLC Enter Collaboration, Hope to Better Understand Inflammatory Diseases
PAO-M05-18-NI-002
Strategic Collaboration
United Neuroscience Ltd. and Boston University Lee Goldstein Laboratory Enter Collaboration, Targeting Treatment and Prevention of Chronic Traumatic Encephalopathy (CTE)
PAO-M04-18-NI-012
Approval
Fresenius Kabi Announces New Approval and Immediate Availability of Daptomycin for Injection
PR-M04-18-NI-58
Drug Discovery
"Transcriptional wiring" of cancer genes can be resolved using Lexogen's SLAMseq and QuantSeq technologies to facilitate drug discovery
PR-M04-18-NI-38
Laboratory Testing
Creating Comprehensive Solutions through Laboratory Testing
PAP-Q1-18-CL-011
Innovation
LYNPARZA® (olaparib) Receives Positive EU CHMP Opinion in Platinum-Sensitive Relapsed Ovarian Cancer
PR-M02-18-NI-100
Drug Development
Pfizer Announces Update on European Marketing Authorization Application for SUTENT® (sunitinib) in Adult Patients at High Risk of Recurrent Renal Cell Carcinoma
PR-M02-18-NI-99
Oncology
Pfizer Receives Positive CHMP Opinion for Two Hematology Medicines, MYLOTARG™and BOSULIF®
PR-M02-18-NI-98
«
3
6
»
